Patient's Outcome Prognostic Factors Clinical Trial
Official title:
Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era
Introduction High dose chemotherapy followed by Autologous Stem Cell Transplantation (ASCT)
is a therapeutic option in follicular Lymphoma after first line treatment failure. The
clinical characteristics and outcome of FL patients who relapsed after HDT+ASCT and
therapeutic management in the rituximab era are not well known and may represent a difficult
challenge.
Patients and Methods: The investigators conducted a retrospective analysis of FL patients who
relapsed after HDT+ASCT in four French centers treated between 2000 and 2014. Clinical
records were reviewed for clinical characteristics and treatment strategy at relapse. The
investigators aimed to identify prognostic factors related to patient's outcome.
n/a